PharmaCyte Biotech, Inc. (PMCB)

PharmaCyte Biotech Statistics

Total Valuation

PMCB has a market cap or net worth of $6.34 million. The enterprise value is -$6.73 million.

Market Cap	6.34M
Enterprise Value	-6.73M

Important Dates

The last earnings date was Monday, September 15, 2025, after market close.

Earnings Date	Sep 15, 2025
Ex-Dividend Date	n/a

Share Statistics

PMCB has 6.80 million shares outstanding. The number of shares has decreased by -15.90% in one year.

Current Share Class	6.80M
Shares Outstanding	6.80M
Shares Change (YoY)	-15.90%
Shares Change (QoQ)	-0.86%
Owned by Insiders (%)	2.88%
Owned by Institutions (%)	11.27%
Float	6.07M

Valuation Ratios

The trailing PE ratio is 160.47.

PE Ratio	160.47
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.16
P/TBV Ratio	0.16
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 18.01

Current Ratio	18.01
Quick Ratio	17.01
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -2.33% and return on invested capital (ROIC) is -5.12%.

Return on Equity (ROE)	-2.33%
Return on Assets (ROA)	-4.29%
Return on Invested Capital (ROIC)	-5.12%
Return on Capital Employed (ROCE)	-8.98%
Revenue Per Employee	n/a
Profits Per Employee	$22,227
Employee Count	2
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -51.16% in the last 52 weeks. The beta is -0.24, so PMCB's price volatility has been lower than the market average.

Beta (5Y)	-0.24
52-Week Price Change	-51.16%
50-Day Moving Average	0.99
200-Day Moving Average	1.30
Relative Strength Index (RSI)	44.27
Average Volume (20 Days)	109,896

Short Selling Information

The latest short interest is 132,286, so 1.95% of the outstanding shares have been sold short.

Short Interest	132,286
Short Previous Month	11,391
Short % of Shares Out	1.95%
Short % of Float	2.18%
Short Ratio (days to cover)	1.34

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-3.96M
Pretax Income	-1.14M
Net Income	44,453
EBITDA	n/a
EBIT	-3.96M
Earnings Per Share (EPS)	$0.01

Balance Sheet

The company has $13.44 million in cash and n/a in debt, giving a net cash position of $13.44 million or $1.98 per share.

Cash & Cash Equivalents	13.44M
Total Debt	n/a
Net Cash	13.44M
Net Cash Per Share	$1.98
Equity (Book Value)	43.59M
Book Value Per Share	6.41
Working Capital	18.05M

Cash Flow

Operating Cash Flow	-4.60M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PMCB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	15.90%
Shareholder Yield	15.90%
Earnings Yield	0.66%
FCF Yield	n/a

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on July 12, 2021. It was a reverse split with a ratio of 1:1,499.93.

Last Split Date	Jul 12, 2021
Split Type	Reverse
Split Ratio	1:1,499.93

Scores

Altman Z-Score	n/a
Piotroski F-Score	2